Movement time and aging: A normative study in healthy subjects with the "Movement Time Analyzer®"

Aging Clinical and Experimental Research

Volumn 17, Issue 3, 2005, Pages 207-210

  Nicoletti, Giuseppe ^a,b   Arabia, Gennarina ^a   Pugliese, Pierfrancesco ^a   Torchia, Giusi ^a   Pucci, Franco ^a   Gambardella, Antonio ^a,b   Quattrone, Aldo ^a,b   Zappia, Mario ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Aging; Movement time; Normative data; Parkinson's disease

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BODY MOVEMENT; BRADYKINESIA; CLINICAL PRACTICE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LEFT HANDEDNESS; MALE; NORMAL HUMAN; PARKINSON DISEASE; RIGHT HANDEDNESS; SEX DIFFERENCE; TASK PERFORMANCE; TIME;

EID: 27644566631     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03324598     Document Type: Article

References (16)

1. Marsden CD. Slowness of movement in Parkinson's disease. Mov Disord 1989; 4 (Suppl 1): 26-37.
2. Wilson SAK. Disorders of motility and of muscle tone with special reference to the corpus striatum. Lancet 1925; 2: 1-10.
3. Zappia M, Montesanti R, Colao R, Quattrone A. Usefulness of movement time in the assessment of Parkinson's disease. J Neurol 1994; 241: 543-50.
4. Quattrone A, Zappia M. Oral pulse levodopa therapy in mild Parkinson's disease. Neurology 1993; 43: 1161-3.
5. Zappia M, Montesanti R, Colao R, et al. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease. Mov Disord 1997; 12: 103-6.
6. Zappia M, Oliveri RL, Bosco D, et al. The long-duration response to L-dopa in the treatment of early PD. Neurology 2000; 54: 1910-5.
7. Quattrone A, Zappia M, Aguglia U, et al. The subacute levodopa test for evaluating long duration response in Parkinson's disease. Ann Neurol 1995; 38: 389-95.
8. Zappia M, Colao R, Montesanti R, et al. Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease. Ann Neurol 1997; 42: 245-8.
9. Zappia M, Oliveri RL, Montesanti R, et al. Loss of long-duration response to levodopa over time in PD: implications for wearing-off. Neurology 1999; 52: 763-7.
10. Zappia M, Bosco D, Plastino M, et al. Pharmacodynamics of the long-duration response to levodopa in PD. Neurology 1999; 53: 557-60.
11. Polio A, Torre E, Lopiano L, et al. Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport 2002; 13: 1383-6.
12. Kauranen K, Vanharanta H. Influences of aging, gender and handedness on motor performance of upper and lower extremities. Percept Mot Skills 1996; 82: 515-25.
13. York JL, Biederman I. Effect of age and sex on reciprocal tapping performance. Percept Mot Skills 1990; 71: 675-84.
14. Shimoyama I, Ninchoji T, Uemura K. The finger-tapping test. A quantitative analysis. Arch Neurol 1990; 47: 681-4.
15. Smith CD, Umberger GH, Manning EL, et al. Critical decline in fine motor hand movements in human aging. Neurology 1999; 53: 1458-61.
16. Hallet M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980; 103: 301-14.